Yes. Although we got an approval from Health Canada in February of last year and were preparing for the launch of the product, we faced unexpected quality problems. While we were fixing these, market needs for the vaccine evolved toward bivalent vaccines. Our vaccine is monovalent. Therefore, we just.... The approved vaccine was irrelevant, because of the market evolution.
On March 23rd, 2023. See this statement in context.